ArthurSantoraMD

PubMed

• 10 citations
  Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial
  Socrates E. Papapoulos, Henry G. Bone, Felicia Cosman, David W. Dempster, Michael R. McClung, Toshitaka Nakamura, José Fernando Molina Restrepo, Mary L. Bouxsein, D Co...> ;Journal of Bone and Mineral Research. 2021 Apr 27
• 2 citations
  Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis
  Kenneth G. Saag, Felicia Cosman, T. J. de Villiers, Bente L. Langdahl, Boyd B. Scott, Andrew Denker, Annpey Pong, Arthur C. Santora> ;Osteoporosis International. 2021 Feb 19
• 7 citations
  Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis
  Neil Binkley, Eric S. Orwoll, Roland Chapurlat, Bente L. Langdahl, Boyd B. Scott, H. Giezek, Arthur C. Santora> ;Osteoporosis International. 2021 Jan 1
• 22 citations
  History of alendronate
  Steven R. Cummings, Arthur C. Santora, Dennis M. Black, R. Graham G. Russell> ;Bone. 2020 Aug 1
• 15 citations
  Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) ...
  Robert R. Recker, David W. Dempster, Bente L. Langdahl, Hilde Giezek, Seth Clark, Graham Ellis, Tobias J. de Villiers, Ivo Valter, Cristiano A. F. Zerbini, D Cohn, Art...> ;Journal of Bone and Mineral Research. 2020 Jul 1
• 5 citations
  Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting
  Erin S. LeBlanc, A. G. Rosales, Harry K. Genant, Richard M. Dell, Darin Friess, David L. Boardman, Arthur C. Santora, Douglas C. Bauer, A. E. de Papp, Dennis M. Black,...> ;Osteoporosis International. 2019 Feb 26
• 1 citations
  Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand.
  Thawee Songpatanasilp, Sattaya Rojanasthien, Pansak Sugkraroek, Boonsong Ongphiphadhanakul, Lamar Robert, Chongchit Sripun Robert, Sirichai Luevitoonvechkij, Arthur C....> ;BMC Musculoskeletal Disorders. 2018 Nov 6
• 20 citations
  Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Set...
  Erin S. LeBlanc, A. Gabriela Rosales, Dennis M. Black, Harry K. Genant, Richard M. Dell, Darin Friess, David L. Boardman, Douglas C. Bauer, Anne E. de Papp, Arthur C. ...> ;Journal of Bone and Mineral Research. 2017 Nov 1
• 13 citations
  A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
  Felicia Cosman, N. Gilchrist, Michael R. McClung, J. Foldes, T. J. de Villiers, Arthur C. Santora, Albert T. Leung, Suvajit Samanta, Norman Heyden, J.P. McGinnis, Eliz...> ;Osteoporosis International. 2016 Jan 1
• Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacat...
  Bone, H. G.,Dempster, D. W.,Eisman, J. A.,Greenspan, S. L.,McClung, M. R.,Nakamura, T.,Papapoulos, S.,Shih, W. J.,Rybak-Feiglin, A.,Santora, A. C.,Verbruggen, N.,Leung...> ;Osteoporos Int. 2015 Sep 12
• Erratum to: Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, act...
  Zhang, Z. L.,Liao, E. Y.,Xia, W. B.,Lin, H.,Cheng, Q.,Wang, L.,Hao, Y. Q.,Chen, D. C.,Tang, H.,De Peng, Y.,You, L.,He, L.,Hu, Z. H.,Song, C. L.,Wei, F.,Wang, J.,Zhang,...> ;Osteoporos Int. 2015 Sep 18
• Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparat...
  Zhang ZL, Liao EY, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, De Peng Y, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L, Santora AC> ;Osteoporos Int. 2015-09-01
• Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture ...
  Bone, H. G.,Dempster, D. W.,Eisman, J. A.,Greenspan, S. L.,McClung, M. R.,Nakamura, T.,Papapoulos, S.,Shih, W. J.,Rybak-Feiglin, A.,Santora, A. C.,Verbruggen, N.,Leung...> ;Osteoporos Int. 2014 Nov 30
• 31 citations
  A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study of the Calcium-Sensing Receptor Antagonist MK-5442 in the Treatment of Postmenopausal Women With Osteopor...
  Johan Halse, Susan L. Greenspan, Felicia Cosman, Graham Ellis, Arthur C. Santora, Albert Leung, Norman Heyden, Suvajit Samanta, Steven Doleckyj, Elizabeth Rosenberg, A...> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Aug 28
• 14 citations
  Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis
  Christian Roux, Neil Binkley, Steven Boonen, Douglas P. Kiel, Stuart H. Ralston, Jean-Yves Reginster, Annpey Pong, Elizabeth Rosenberg, Arthur C. Santora, Focus-D Inve...> ;Calcified Tissue International. 2014 Feb 1
• 28 citations
  Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dos...
  T. Nakamura, Masataka Shiraki, Masao Fukunaga, Tatsushi Tomomitsu, Arthur C. Santora, R. Tsai, G. Fujimoto, M. Nakagomi, H. Tsubouchi, Elizabeth Rosenberg, S. Uchida> ;Osteoporosis International. 2014 Jan 1
• 41 citations
  BMD changes and predictors of increased bone loss in postmenopausal women after a 5‐year course of alendronate
  Brian McNabb, Eric Vittinghoff, Ann V. Schwartz, Richard Eastell, Douglas C. Bauer, Kristine E. Ensrud, Elizabeth Rosenberg, Arthur C. Santora, Elizabeth Barrett-Conno...> ;Journal of Bone and Mineral Research. 2013 Jun 1
• 20 citations
  In Vitro and In Vivo Responses to High and Low Doses of Nitrogen-Containing Bisphosphonates Suggest Engagement of Different Mechanisms for Inhibition of Osteoclastic B...
  John E. Fisher, Elizabeth Rosenberg, Arthur C. Santora, Alfred A. Reszka> ;Calcified Tissue International. 2013 Feb 24
• 128 citations
  Incidence and demography of femur fractures with and without atypical features
  Adrianne C. Feldstein, Dennis M. Black, Nancy Perrin, A. Gabriela Rosales, Darin Friess, David L. Boardman, Richard M. Dell, Arthur C. Santora, Julie Chandler, Mary M....> ;Journal of Bone and Mineral Research. 2012 May 1
• 15 citations
  Effect of alendronate and vitamin D3 on fractional calcium absorption in a double‐blind, randomized, placebo‐controlled trial in postmenopausal osteoporotic women
  Sue A. Shapses, David L. Kendler, Richard Robson, Karen E. Hansen, Robert M. Sherrell, M. Paul Field, Eric Woolf, Yulia Berd, Ann Marie Mantz, Arthur C. Santora> ;Journal of Bone and Mineral Research. 2011 Aug 1
• 180 citations
  Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
  John A. Eisman, Henry G. Bone, David J. Hosking, Michael R. McClung, Ian R. Reid, René Rizzoli, Heinrich Resch, N. Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Roma...> ;Journal of Bone and Mineral Research. 2011 Feb 1
• 229 citations
  Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.
  Henry G. Bone, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, N. Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B Avery Ince> ;Journal of Bone and Mineral Research. 2009 Dec 14
• 7 citations
  Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, contr...
  Neil Binkley, Johann D. Ringe, John I. Reed, Östen Ljunggren, Michael F. Holick, Helmut W. Minne, Minzhi Liu, Amy Lamotta, Joseph West, Arthur C. Santora> ;Bone. 2009 Apr 1
• 3 citations
  Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk
  Henry G. Bone, Arthur C. Santora, Arghya Chattopadhyay, Uri A. Liberman> ;Journal of Bone and Mineral Research. 2005 Nov 1
• 402 citations
  Osteoporosis and Fracture Risk in Women of Different Ethnic Groups
  Elizabeth Barrett-Connor, Ethel S. Siris, Lois E. Wehren, Paul D. Miller, Thomas A. Abbott, Marc L. Berger, Arthur C. Santora, Louis M. Sherwood> ;Journal of Bone and Mineral Research. 2004 Oct 18
• Join now to see all

Journal Articles

• Open-Label Study of Treatment with Alendronate Sodium plus Vitamin D in Men and Women with Osteoporosis in Thailand  
  Arthur Santora, MD, BioMed Central